SEARCH WITHIN CONTENT
Citation Information : Immunohematology. Volume 34, Issue 1, Pages 1-3, DOI: https://doi.org/10.21307/immunohematology-2018-001
License : (Transfer of Copyright)
Published Online: 16-October-2019
The masking of clinically significant alloantibodies by warm autoantibodies presents challenges in pretransfusion testing. The adoption of transfusion practices such as the issuing of “least incompatible” red blood cells (RBCs) without a complete antibody workup is potentially unsafe for patients. Several autoadsorption methods can be used to remove autoantibody reactivity. ZZAP treatment of autologous RBCs is an efficient way to prepare the cells for autoadsorption. Autoadsorbed serum or plasma can then be used to remove autoantibody reactivity and identify clinically significant alloantibodies.